Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults

Conditions: Schizophrenia

Interventions: Drug: VV119 2mg; Drug: VV119 4mg; Drug: VV119 6mg; Drug: Aripiprazole tablet; Drug: Placebo

Sponsors: Vigonvita Life Sciences

Not yet recruiting